Jianbo Feng
Hengyang, 421001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
DCC-2036 induces repolarization of TAMs to M1 type and enhances CD8+ T cell immunity in TNBC.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 09, 2025
Lactylation: A new direction for tumor-targeted therapy.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: March 25, 2025
Role of ubiquitin-specific proteases in programmed cell death of breast cancer cells.
Journal: Genes & diseases
Published: January 20, 2024
Role of ferroptosis and ferroptosis-related long non'coding RNA in breast cancer.
Journal: Cellular & molecular biology letters
Published: December 18, 2023
Promoter hypomethylated PDZK1 acts as a tumorigenic gene in glioma by interacting with AKT1.
Journal: Aging
Published: November 15, 2023
Biomarkers-Based Cost-Effectiveness of Toripalimab Plus Chemotherapy for Patients with Treatment-Naive Advanced Non-Small Cell Lung Cancer.
Journal: Advances in therapy
Published: July 26, 2023
Protein Phase Separation: New Insights into Carcinogenesis.
Journal: Cancers
Published: November 06, 2022
Non-coding RNAs in breast cancer: Implications for programmed cell death.
Journal: Cancer letters
Published: June 27, 2022
Inhibitory effect of the novel tyrosine kinase inhibitor DCC-2036 on triple-negative breast cancer stem cells through AXL-KLF5 positive feedback loop.
Journal: Cell death & disease
Published: March 02, 2022
Identification of an AXL kinase inhibitor in triple-negative breast cancer by structure-based virtual screening and bioactivity test.
Journal: Chemical biology & drug design
Published: July 12, 2021
Last Updated: 09/26/2026